1. Home
  2. RGEN vs XPEV Comparison

RGEN vs XPEV Comparison

Compare RGEN & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • XPEV
  • Stock Information
  • Founded
  • RGEN 1981
  • XPEV 2015
  • Country
  • RGEN United States
  • XPEV China
  • Employees
  • RGEN N/A
  • XPEV N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • XPEV Auto Manufacturing
  • Sector
  • RGEN Health Care
  • XPEV Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • XPEV Nasdaq
  • Market Cap
  • RGEN 7.6B
  • XPEV 7.6B
  • IPO Year
  • RGEN N/A
  • XPEV 2020
  • Fundamental
  • Price
  • RGEN $124.73
  • XPEV $12.74
  • Analyst Decision
  • RGEN Buy
  • XPEV Buy
  • Analyst Count
  • RGEN 11
  • XPEV 5
  • Target Price
  • RGEN $190.25
  • XPEV $10.82
  • AVG Volume (30 Days)
  • RGEN 661.4K
  • XPEV 15.1M
  • Earning Date
  • RGEN 11-12-2024
  • XPEV 11-19-2024
  • Dividend Yield
  • RGEN N/A
  • XPEV N/A
  • EPS Growth
  • RGEN N/A
  • XPEV N/A
  • EPS
  • RGEN N/A
  • XPEV N/A
  • Revenue
  • RGEN $639,915,000.00
  • XPEV $4,986,920,687.00
  • Revenue This Year
  • RGEN $0.44
  • XPEV $35.42
  • Revenue Next Year
  • RGEN $12.13
  • XPEV $55.58
  • P/E Ratio
  • RGEN N/A
  • XPEV N/A
  • Revenue Growth
  • RGEN N/A
  • XPEV 72.08
  • 52 Week Low
  • RGEN $113.50
  • XPEV $6.55
  • 52 Week High
  • RGEN $211.13
  • XPEV $18.74
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 36.21
  • XPEV 52.70
  • Support Level
  • RGEN $137.27
  • XPEV $11.74
  • Resistance Level
  • RGEN $154.48
  • XPEV $15.68
  • Average True Range (ATR)
  • RGEN 7.09
  • XPEV 0.69
  • MACD
  • RGEN -0.55
  • XPEV 0.00
  • Stochastic Oscillator
  • RGEN 9.74
  • XPEV 38.14

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About XPEV XPeng Inc.

Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.

Share on Social Networks: